At the Forefront of Care for Patients with Worsening Heart Failure: New and Emerging Treatment Options is organized by Tarsus CNS.
Course Opens: 01/28/2025
Course Expires: 01/28/2026
Description:
Welcome to our webcast on worsening heart failure. Heart failure remains one of the most challenging conditions to manage, with worsening heart failure being a critical area where suboptimal outcomes persist. While foundational therapies such as beta-blockers, ACE inhibitors, mineralocorticoid receptor antagonists, and ARNIs remain integral to heart failure management, advances in our understanding of heart failure pathophysiology have opened the door to newer, innovative therapeutic options, such as SGLT-2i, sCG stimulators and SGLT1/2 inhibitors.
This webcast is designed to deliver expert perspectives through a dynamic combination of didactic presentations and interspersed discussions. Together, we will explore the burden of worsening heart failure, review current treatment approaches, and delve into the clinical application of current and newer therapies through a patient case.
Learning Objectives:
After completing this activity, the participant should be better able to:
Joint Providership Statement:
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Cardiometabolic Health Congress (CMHC). PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Education:
PACE designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.25 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.
Pharmacy Continuing Education:
PACE designates this continuing education activity for 1.25 contact hours (0.125 CEUs) of the Accreditation Council for Pharmacy Education.
For Pharmacists: Upon completing the post-test and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 – 6 weeks.
Available Credit:
1.25 ACPE Pharmacy
1.25 AMA PRA Category 1 Credit™
1.25 ANCC
1.25 Participation
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved